Empagliflozin 12.5 Mg & Metformin 1000 Mg Hydrochloride Tablets - Emprivo M 12.5/1000 Tablets

Emprivo M 12.5/1000 Tablets
Composition:- Empagliflozin 12.5 mg + Metformin HCL 1000 mg

Emprivo M 12.5/1000 Tablets – Empagliflozin 12.5 Mg & Metformin 1000 Mg Hydrochloride Tablets combine Empagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, with Metformin, a biguanide, to provide robust glycemic control through complementary mechanisms:
• Empagliflozin: Reduces blood glucose by preventing renal glucose reabsorption, promotes weight management, and offers cardiovascular protection.
• Metformin: Lowers hepatic glucose production, enhances insulin sensitivity, and improves peripheral glucose uptake.
Together, they offer a dual-action approach for effective Type 2 Diabetes management.

Key Points of Empagliflozin 12.5 Mg & Metformin 1000 Mg Hydrochloride Tablets – Emprivo M 12.5/1000 Tablets
• Dual Mechanism for Superior Glycemic Control – Combines SGLT2 inhibition and biguanide action for effective blood sugar regulation.
• Weight Management & Cardiovascular Support – Helps reduce weight and lowers the risk of heart-related complications in diabetic patients.
• Convenient Once-Daily Dose – Simplifies treatment, improving adherence and patient convenience.

Can be Prescribed by:
• Diabetologists
• General Physicians
• Cardiologists
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.